Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Oncology Letters|March 20, 2018
Effect of HK2, PKM2 and LDHA on Cetuximab efficacy in metastatic colorectal cancerHaohua Wang, Roujun Peng, Xiuxing Chen, et al.
Breast (Edinburgh, Scotland)|August 17, 2011
Patients 35 years old or younger with operable breast cancer are more at risk for relapse and survival: a retrospective matched case-control studyRoujun Peng, Shusen Wang, Yanxia Shi, et al.
Clinical and Experimental Medicine|August 9, 2023
Characteristics and classification of first primary cancer patients with second primary cancer: a population-based cohort studyZhaohui Ruan, Yuetong Zhang, Zhaozhi Li, et al.
Cancer Science|May 26, 2012
Distribution, clinicopathologic features and survival of breast cancer subtypes in Southern ChinaCong Xue, Xi Wang, Roujun Peng, et al.
The Oncologist|November 27, 2020
A Phase II Study of Fulvestrant 500 mg as Maintenance Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Patients with Advanced Breast Cancer After First-Line ChemotherapyFei Xu, Qiufan Zheng, Wen Xia, et al.
Medical Oncology (Northwood, London, England)|April 30, 2011
Classical CMF regimen as adjuvant chemotherapy for triple-negative breast cancer may be more effective compared with anthracycline or taxane-based regimensShusen Wang, Yanxia Shi, Zhongyu Yuan, et al.
Frontiers of Medicine|February 10, 2015
Tumor growth and metastasis can be inhibited by maintaining genomic stability in cancer cellsYi Liang, Qisheng Feng, Jian Hong, et al.
Anticancer Research|July 26, 2017
Nomogram Model of LNR Predicts Survival in Premenopausal Patients with Node-positive Luminal Breast CancerTao Qin, Yin-Duo Zeng, Qianyi Lu, et al.
Scientific Reports|July 25, 2020
First-line cetuximab improves the efficacy of subsequent bevacizumab for RAS wild-type left-sided metastatic colorectal cancer: an observational retrospective studyShousheng Liu, Chang Jiang, Lin Yang, et al.
Medicine|October 9, 2015
Selective Estrogen Receptor Modulator-Associated Nonalcoholic Fatty Liver Disease Improved Survival in Patients With Breast Cancer: A Retrospective Cohort AnalysisQiufan Zheng, Fei Xu, Man Nie, et al.
Pageof 4